Private practice, Houston, TX.
Laboratory for Applied Periodontal and Craniofacial Regeneration, The Dental College of Georgia, Institute for Regenerative and Reparative Medicine, Augusta University, Augusta Georgia.
J Periodontol. 2016 Jun;87(6):645-53. doi: 10.1902/jop.2016.150459. Epub 2016 Feb 1.
Connective tissue grafts (CTGs) and coronally advanced flaps (CAFs) do not regenerate periodontal attachment apparatus when used to treat gingival recessions (GRs). Instead of generating new bone, cementum, and inserting periodontal ligament fibers, CTG+CAF repairs through a long epithelial junction and connective tissue attachment. Enamel matrix derivatives (EMDs) have demonstrated proof-of-principle that periodontal regeneration can be achieved, although data are limited.
Three patients, each requiring extraction of four premolars before orthodontic treatment, were enrolled in a randomized, open-label study. Two months after induction of Miller Class I and II GR, each patient received EMD+CAF for three teeth and CTG+CAF for one tooth for root coverage. Nine months after root coverage, all four premolars from each of the three patients were surgically extracted en bloc for histologic and microcomputed tomography (micro-CT) analysis, looking for evidence of periodontal regeneration. Standard clinical measurements, radiographs, and intraoral photographs were taken over prescribed time points.
Seven of the nine teeth treated with EMD+CAF demonstrated varying degrees of periodontal regeneration, detailed through histology with new bone, cementum, and inserting fibers. Micro-CT corroborated these findings. None of the three teeth treated with CTG+CAF showed periodontal regeneration. Clinical measurements were comparable for both treatments. One instance of root resorption and ankylosis was noted with EMD+CAF.
EMD+CAF continues to show histologic evidence of periodontal regeneration via human histology, this being the largest study (nine teeth) examining its effect when treating GR. The mechanism of action, ideal patient profile, and criteria leading to predictable regeneration are in need of further exploration.
在治疗牙龈退缩(GR)时,结缔组织移植物(CTG)和冠向推进瓣(CAF)不能再生牙周附着装置。CTG+CAF 修复通过长的上皮结合和结缔组织附着,而不是产生新的骨、牙骨质和插入牙周韧带纤维。尽管数据有限,但牙釉质基质衍生物(EMD)已经证明了牙周再生是可行的。
三名需要在正畸治疗前拔除四颗前磨牙的患者参与了一项随机、开放标签研究。在诱导Miller Ⅰ类和Ⅱ类 GR 后两个月,每位患者接受 EMD+CAF 治疗三颗牙,CTG+CAF 治疗一颗牙,以获得根覆盖。在根覆盖后 9 个月,三名患者的每颗四颗前磨牙都被整块手术取出,用于组织学和微计算机断层扫描(micro-CT)分析,以寻找牙周再生的证据。在规定的时间点进行了标准的临床测量、射线照相和口腔内照片拍摄。
用 EMD+CAF 治疗的 9 颗牙中的 7 颗显示出不同程度的牙周再生,通过组织学详细描述了新骨、牙骨质和插入纤维。micro-CT 证实了这些发现。用 CTG+CAF 治疗的 3 颗牙均未显示牙周再生。两种治疗方法的临床测量值相当。在 EMD+CAF 治疗中,有一例根吸收和粘连。
EMD+CAF 通过人体组织学继续显示牙周再生的组织学证据,这是研究其在治疗 GR 时效果的最大研究(9 颗牙)。其作用机制、理想的患者特征和导致可预测再生的标准仍需要进一步探索。